BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 38167072)

  • 1. Identification of a novel lymphangiogenesis signature associated with immune cell infiltration in colorectal cancer based on bioinformatics analysis.
    Liu H; Shi H; Sun Y
    BMC Med Genomics; 2024 Jan; 17(1):2. PubMed ID: 38167072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
    Yang C; Cao F; Huang S; Zheng Y
    Front Immunol; 2021; 12():717505. PubMed ID: 34335633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of an RBP gene signature for prognosis prediction in colorectal cancer based on WGCNA.
    Cao L; Duan L; Zhang R; Yang W; Yang N; Huang W; Chen X; Wang N; Niu L; Zhou W; Chen J; Li Y; Zhang Y; Liu J; Fan D; Liu H
    Hereditas; 2023 Mar; 160(1):10. PubMed ID: 36895014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A signature based on 11 autophagy genes for prognosis prediction of colorectal cancer.
    Chen S; Wang Y; Wang B; Zhang L; Su Y; Xu M; Zhang M
    PLoS One; 2021; 16(10):e0258741. PubMed ID: 34699544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and validation of an immune prognostic signature in colorectal cancer.
    Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
    Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A five-immune-related genes-based prognostic signature for colorectal cancer.
    Zhu L; Wang H; Wang Z
    Int Immunopharmacol; 2020 Nov; 88():106866. PubMed ID: 32781411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immune-related gene prognostic index for predicting prognosis in patients with colorectal cancer.
    Li C; Wirth U; Schardey J; Ehrlich-Treuenstätt VV; Bazhin AV; Werner J; Kühn F
    Front Immunol; 2023; 14():1156488. PubMed ID: 37483596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of a Novel Immune-Related mRNA Signature to Predict the Prognosis and Immune Characteristics of Human Colorectal Cancer.
    Li J; Han T; Wang X; Wang Y; Chen X; Chen W; Yang Q
    Front Genet; 2022; 13():851373. PubMed ID: 35401707
    [No Abstract]   [Full Text] [Related]  

  • 10. Cancer-associated fibroblast-related gene signatures predict survival and drug response in patients with colorectal cancer.
    Zhang L; Xu C; Wang SH; Ge QW; Wang XW; Xiao P; Yao QH
    Front Genet; 2022; 13():1054152. PubMed ID: 36506313
    [No Abstract]   [Full Text] [Related]  

  • 11. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
    Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W
    Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the shared gene signature and biological mechanism between type 2 diabetes and colorectal cancer.
    Liu X; Li D; Gao W; Zhao W; Jin L; Chen P; Liu H; Zhao Y; Dong G
    Front Genet; 2023; 14():1202849. PubMed ID: 37876593
    [No Abstract]   [Full Text] [Related]  

  • 13. A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer.
    Zhang C; Zeng C; Xiong S; Zhao Z; Wu G
    Sci Rep; 2022 Nov; 12(1):18688. PubMed ID: 36333388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of glutamine metabolism-related gene signature to predict colorectal cancer prognosis.
    Xie Y; Li J; Tao Q; Wu Y; Liu Z; Zeng C; Chen Y
    J Cancer; 2024; 15(10):3199-3214. PubMed ID: 38706895
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer.
    Luan L; Dai Y; Shen T; Yang C; Chen Z; Liu S; Jia J; Li Z; Fang S; Qiu H; Cheng X; Yang Z
    Front Immunol; 2022; 13():951455. PubMed ID: 36189298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer.
    Zhou M; Lv S; Hou Y; Zhang R; Wang W; Yan Z; Li T; Gan W; Zeng Z; Zhang F; Yang M
    Front Immunol; 2022; 13():994874. PubMed ID: 36330513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis analysis of necroptosis-related genes in colorectal cancer based on bioinformatic analysis.
    Liang X; Cheng Z; Chen X; Li J
    Front Genet; 2022; 13():955424. PubMed ID: 36046241
    [No Abstract]   [Full Text] [Related]  

  • 18. SPOCK1 and POSTN are valuable prognostic biomarkers and correlate with tumor immune infiltrates in colorectal cancer.
    Gan C; Li M; Lu Y; Peng G; Li W; Wang H; Peng Y; Hu Q; Wei W; Wang F; Liu L; Zhao Q
    BMC Gastroenterol; 2023 Jan; 23(1):4. PubMed ID: 36611136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An age stratified analysis of the biomarkers in patients with colorectal cancer.
    Yao H; Li C; Tan X
    Sci Rep; 2021 Nov; 11(1):22464. PubMed ID: 34789836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of hub genes in colorectal cancer based on weighted gene co-expression network analysis and clinical data from The Cancer Genome Atlas.
    Zhang Y; Luo J; Liu Z; Liu X; Ma Y; Zhang B; Chen Y; Li X; Feng Z; Yang N; Feng D; Wang L; Song X
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34308980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.